In order to investigate activation and internalization of c-kit we created a functional c-kit-EGFP chimera by inserting EYFP (enhanced yellow fluorescent protein) within the extracellular domain of c-kit immediately downstream of the signal sequence, SS-EYFP-kit. This location was chosen because the C-terminal fusion of EGFP to c-kit unexpectedly caused constitutive activation of the c-kit tyrosine kinase. As analysed in fixed cells and by real time imaging in vivo, SCF induced activation led to internalization of the fusion construct and translocation to punctate structures resembling vesicles. Analysis of the internalization process by time lapse imaging revealed high mobility and discontinuous movement of these vesicles and their predominantly radial tracks. Two subsets of vesicles were observed: Traffic of the majority of vesicles was directed from the periphery to the center of the cell and most likely represents the internalization of activated receptor molecules via the endosomal pathway. However, some vesicular structures were observed to move towards the periphery of the cell and probably contain newly synthesized protein to replace internalized receptor molecules. The calculated velocity of moving vesicles ranged from 0.05 to 0.2 μm per se. Vesicle formation upon SCF induced dimerization of the receptor was strictly dependent on kinase activity of c-kit. Treatment of cells with phenylarsine oxide, an agent blocking receptor internalization, prior to SCF stimulation resulted in abrogation of the translocation of the chimera to vesicles whereas accumulation of vesicles was observed when cells were treated with proteasome inhibitors. Cholesterol depletion of the cell membrane by methyl-β-cyclodextrin resulted in dose dependent reduction of receptor internalization indicating that c-kit may be present in lipid rafts or that intact lipid rafts are required for efficient internalization of the receptor. Using the induction of vesicular structures as a sign of efficient internalization of the receptor analysis of mutant c-kit constructs deficient either in activation of PI3-Kinase or Src revealed that internalization of c-kit is dependent on recruitment of Src but not PI3-Kinase.
The integrity of the c-kit signaling pathway is crucial for normal hematopoiesis, melanogenesis and gametogenesis (for a review see (Broudy, 1997)). Activation of this type III receptor tyrosine kinase (RTK) results from the binding of its ligand, stem cell factor (SCF, also known as kit ligand or steel factor), which exists in both soluble and membrane bound form (Langley et al., 1993; Longley et al., 1997). Activation of c-kit leads to autophosphorylation of the cytoplasmic tail encoding the tyrosine kinase and recruitment of a variety of signaling proteins to the receptor. In addition to the multitude of signaling pathways directly activated by c-kit (Blume-Jensen et al., 2000; Caruana et al., 1999; Deberry et al., 1997; Krystal et al., 1998; Serve et al., 1995; Thommes et al., 1999; Timokhina et al., 1998; Wakioka et al., 1999) there is evidence that the c-kit receptor also takes part in cytokine receptor cross talk in which type I receptors, e.g. the erythropoietin receptor, are activated by c-kit (Liu et al., 1994; Wu et al., 1995). In addition, c-kit can be activated by Bcr-Abl in absence of its ligand and might in turn function as a multiplier of foreign cytokines or oncogenes (Clarkson et al., 1997; Hallek et al., 1996). Subsequent to SCF induced activation of c-kit ubiquitination and clathrin-mediated internalization of activated c-kit molecules represent a negative feedback mechanism, which controls SCF mediated c-kit activation (Broudy et al., 1999; Miyazawa et al., 1994). It has been shown that after ligand induced downregulation of c-kit new protein production is necessary for reappearance of the c-kit receptor on the cell surface (Shimizu et al., 1996).
Fusion of EGFP to growth factor receptors has mainly been used to study receptor internalization following ligand-induced activation (Carter and Sorkin, 1998). The generation of different mutants of EGFP (EBFP, EYFP and ECFP) has tremendously enlarged the possibilities of in vivo studies of labeled proteins. Fluorescence resonance energy transfer (FRET) between two fluorochromes as a result of direct interaction of two labeled proteins has expanded the method of colocalization of two proteins (Gordon et al., 1998; Mahajan et al., 1998). A FRET based method in combination with labeled antibodies has been used to further elucidate the SCF induced dimerization process of c-kit molecules (Broudy et al., 1998). However, this procedure is crucially dependent on the use of well-characterized, non-activating and non-blocking antibodies, which recognize the extracellular domain of c-kit, and requires labeling of the cells prior to stimulation. The clear advantages of an EGFP fusion construct are the lack of any labeling procedure. In addition, the construct can be overexpressed and detected in nearly every setting chosen for analysis of subcellular localization, activation or colocalization studies. Disadvantages of the use of EGFP for labeling proteins are primarily the rather large size of EGFP and possible differences in the biology between the fusion and native proteins. Tagging proteins with EGFP always requires thorough controls in order to assess the wild-type like character of the tagged protein. The recommendation to avoid EGFP-tagging close to functional domains of proteins is difficult to follow since tagging of proteins with EGFP is almost exclusively carried out at the N- or C-terminus of proteins. N-terminal regions often contain crucial information for further processing of the protein and C-terminal regions in type III RTKs may contain regulatory domains or docking sites for proteins regulating half life time or enzymatic activity.
The goal of the present study was to create a c-kit EGFP fusion construct in order to visualize and further analyse activation and internalization of c-kit without antibody related labeling procedures. For type III RTKs, the C-terminal fusion of EGFP seemed the most plausible way to obtain a tagged construct. However, the C-terminal fusion unexpectedly led to constitutive activation of c-kit. In contrast, insertion of EYFP directly downstream of the signal sequence did not alter the tyrosine kinase activity and had no influence on SCF induced tyrosine kinase activity. By creating a functional c-kit EGFP fusion construct we have developed a valuable tool to investigate c-kit activation and internalization.
Expression and analysis of different c-kit-EGFP fusion constructs
To create a biologically active c-kit-EGFP fusion construct we fused EGFP in frame to the C-terminus of the murine c-kit cDNA, kit-C-EGFP (Figure 1, upper panel, see Materials and methods for details). The linker region was represented by a glycine repeat, which should reduce steric hindrances and allow correct folding of EGFP and the c-kit C-terminus (Feng et al., 1999; Fischer et al., 1997). Western blot analysis of a c-kit immunoprecipitation using an antibody which recognized an epitope within the murine c-kit C-terminus revealed expression of precursor (lower band) and membrane bound form (upper band) of c-kit (Figure 2a, lower panel, lane 3). Both bands ran about 30 kD higher than the corresponding bands of c-kit WT (Figure 2a, lower panel, lane 2) or of the kinase defective c-kit mutant W42 (D790N) (Figure 2a, lower panel, lane 4) due to the increase of size by the fused EGFP. However, analysis of the tyrosine phosphorylation status of this construct revealed strong constitutive phosphorylation in the absence of SCF (Figure 2a, upper panel, lane 3 and Figure 2b, upper panel, lane 1) in contrast to c-kit WT showing only low level background phosphorylation or the W42 mutant of c-kit lacking detectable tyrosine phosphorylation (Figure 2a, upper panel, compare lanes 2, 3 and 4). Insertion of the silencing mutation W42 into the construct, kit-C-EGFP W42, abolished the constitutive phosphorylation (Figure 2b, upper panel, lane 2). Comparison and alignment of the phosphorylated band with the two forms (precursor and mature form) of kit-C-EGFP revealed that only the mature, membrane-bound form is constitutively activated and phosphorylated (Figure 2b). These observations suggest that C-terminal fusion of EGFP to the entire c-kit cytoplasmic tail selectively activates the membrane-bound form of c-kit.
To choose an inert location for the EGFP and to preserve a functional signal sequence, correct processing, normal glycosylation and membrane localization of a c-kit EGFP chimera we decided to fuse the fluorochrome immediately downstream of the signal sequence with murine c-kit (SS-EYFP-kit, Figure 1, second panel). To facilitate detection of c-kit in future co-localization studies EYFP was inserted instead of EGFP. EYFP is an EGFP mutant differing from EGFP in excitation and emission characteristica. EYFP was equipped with N- and C-terminal glycine linkers to reduce conformational disturbances (Figure 1, lower panel). SS-EYFP-kit overexpressed in COS7 cells (Figure 2c, lower panel, lanes 1 and 2) was not constitutively activated in absence of SCF and became strongly phosphorylated upon addition of SCF (Figure 2c, upper panel, lanes 1 and 2) which indicates that SCF binding to the extracellular portion of c-kit was not perturbed by the 27 kD sized fluorochrome. Only the membrane bound mature form became tyrosine phosphorylated and precursor and membrane bound were present (Figure 2d, upper and lower panels). To verify the biological activity of the chimera, we analysed Aht activation (Figure 2e) and the ability of the constitutively activating mutation D814V to induce IL-3 independent growth of Ba/F3 cells. As shown in Figure 2f Ba/F3 cells expressing cKit D814V or SS-EYFP-Kit D814V showed comparable IL-3 independent proliferation. Ba/F3 cells stably expressing c-kit WT failed to survive or proliferate in media lacking IL-3.
SCF induced internalization of SS-EYFP-kit
Having confirmed that SS-EYFP-kit exhibits correct processing and becomes regularly activated by SCF we were interested in directly imaging the changes in the subcellular distribution pattern of c-kit upon stimulation with SCF. SCF-induced activation of c-kit has been reported to lead to internalization and subsequent degradation of the receptor via the ubiquitin/endosomal pathway. In nonstimulated cells expressing SS-EYFP-kit there was a diffuse to patch like fluorescence signal from the whole cell which is compatible with membrane localization (Figure 3a). Protein production from this construct was evidenced by a bright fluorescence signal from the ER. Imaging of the cells 20 min after addition of SCF revealed the formation of dot like structures distributed over the whole cell (Figure 3b). Z-scan analysis localized these dots to the membrane or to the cytoplasm close to the membrane (Figure 3c and d). These dots resembled vesicles and represented most likely early endosomes containing internalized c-kit molecules.
Time lapse imaging of SCF-induced internalization of SS-EYFP-kit molecules
When living cells expressing SS-EYFP-kit were observed after stimulation with SCF, rapid movement and fluctuation in size and intensity of these vesicles was observed. This observation excluded that formation of the punctate structures was artificially induced by the fixation method previously used. We performed time lapse imaging of living cells to determine direction and velocity of these vesicles. COS7 cells transiently expressing SS-EYFP-kit were stimulated with SCF and cells showing vesicle formation were observed for 200 s. Figure 4a shows a cell, which was observed for 200 s at an imaging cycle time of 10 s. The cellular projection of the summary of all vesicle tracks during 200 s revealed a mainly radial pattern (Figure 4b). Movement of these vesicles mostly appeared to be directed from the periphery to the perinuclear region of the cell (Figure 4c) but the movement in the opposite direction was also observed (Figure 4d). Subsequent vesicles from the same area of the cell moved on the same track revealing guided movement most likely along filamentous structures. Similar observations were made in other cells. Interestingly, movement of the vesicles seemed to be rather non-continuous, since the distances between to subsequent locations vary considerably (in panel c compare distance between t1/t2 and t2/t3, time difference is 10 s). The calculated velocity of this vesicle ranged from 0.05 μm/s (between t1/t2) to 0.2 μm/s (between t2/t3).
The observation of vesicles moving in opposite directions upon stimulation suggested that SCF induced internalization of the receptor was followed by rapid reconstitution of membrane bound c-kit by newly synthesized protein or by recycling of previously internalized receptor molecules. In order to determine if the c-kit receptor undergoes recycling or if new protein synthesis is necessary for reappearance of c-kit at the cell surface we analysed the kinetics of receptor constitution after SCF stimulation with and without treatment of the cells with cycloheximide (Figure 4e). Reconstitution of c-kit on the surface of Ba/F3 cells stably expressing c-kit following SCF stimulation is inhibited in cells treated with cycloheximide. Complete reconstitution of c-kit on the cell surface was observed 90 min after SCF stimulation under the conditions of the c-kit cDNA driven by a constitutively active CMV promoter whereas cells incubated with cycloheximide failed to show significant reconstitution of c-kit (Figure 4e, compare lower left and right panel). Our data are consistent with results from Shimizu et al. (1996) showing that new protein and RNA synthesis are required for reappearance of c-kit after SCF stimulation. In line with these results, the half-life time of c-kit WT was significantly decreased upon stimulation of the receptor with SCF (Figure 4f, compare upper and lower panel). Taken together these results are compatible with the hypothesis that vesicles on their way from the cell periphery to the center contain internalized c-kit receptor whereas the vesicles moving in the opposite direction deliver newly synthesized c-kit molecules to the cell membrane.
Role of c-kit tyrosine kinase activity
For native c-kit it has been shown that inactivation of the kinase domain resulted in a reduced rate of internalization of ligand-receptor complexes (Yee et al., 1994). In order to determine the influence of the kinase activity on vesicle movements two mutants were created: Introduction of the W42 (D790N) mutation into the chimera resulted in the expected loss of inducible tyrosine kinase activity upon binding of SCF (Figure 5a, upper panel, lanes 3 and 4) (Li et al., 1996). An activating mutation (V558G) of c-kit was introduced into the chimera and constitutively activated the fusion construct as anticipated (Figure 5a, upper panel, lanes 5 and 6) (Kanakura et al., 1994).
We compared the localization pattern of SS-EYFP-kit WT, the W42 mutant lacking inducible tyrosine kinase activity, and the constitutively active mutant of c-kit, V558G with or without SCF stimulation (Figure 5). Cells were fixed 20 min after addition of SCF and most cells expressing SS-EYFP-kit WT showed vesicle formation (Figure 5b and c). In contrast, no vesicle formation was observed in cells expressing the kinase defective mutant W42 (Figure 5d and e). Addition of SCF to cells expressing the constitutively active mutant of c-kit V558G did not alter the localization pattern (Figure 5f and g). In some cells constitutive vesicle formation was observed possibly reflecting constitutive internalization since exchange of Valine to Glycine at position 558 causes constitutive dimerization and activation of c-kit independent of ligand induced dimerization.
Role of tyrosine 719 and tyrosines 567/569 for the internalization of activated c-kit
Activation of PI3-Kinase has been reported to be a crucial step in finally directing the internalized PDGF receptor to the degradative pathway following receptor activation (Joly et al., 1995). Phosphotyrosine 719 (Y719) is the binding site of the C-terminal SH2 domain of the p85 subunit of PI3-kinase. Integrity of this site is a prerequisite for c-kit induced PI3-kinase activity resulting in PKB/Akt activation. Accordingly, a tyrosine to phenylalanine mutant of Y719 (SS-EYFP-kit Y719F) failed to induce phosphorylation of co-expressed HA-tagged Akt (Figure 6a, upper panel, compare lanes 1 and 2). Tyrosines 567 and 569 have been reported to be involved in Src activation. To verify the biological activity of SS-EYFP-kit YY567/569FF we compared its capacity to activate Akt and it was found to be equal to SS-EYFP-kit WT (Figure 6b). In order to define the role of PI3-Kinase and Src in the internalization process of SCF activated c-kit we wished to analyse SCF induced internalization of these constructs. Mutation of the PI3-Kinase binding site (Y719) did not influence c-kit internalization as analysed by vesicle formation upon SCF stimulation (Figure 6e and f, compare with SS-EYFP-kit WT, Figure 6c and d), whereas mutation of tyrosines 567 and 569 resulted in a significant decrease of visible dot like structures (Figure 6g and h).
Blocking of c-kit internalization by phenylarsine oxide (PAO) and accumulation of early endosomes by inhibition of proteasomes
In order to further define the vesicular structures containing SS-EYFP-kit after SCF induced activation we exposed the cells to two chemical agents interfering with receptor internalization and degradation at different levels: On the plasma membrane PAO forms ring structures with vicinal sulfhydryl groups and inhibits receptor internalization (Beaumont et al., 1998). Proteasome inhibitors like lactacystin block the proteasomal degradation as a late step of internalization. Cells expressing SS-EYFP-kit WT were preincubated with PAO for 5 min at 50 M, washed and then stimulated with SCF. In cells incubated in DMSO alone, translocation of SS-EYFP-kit to vesicles was clearly visible (Figure 7a), whereas in cells preincubated in PAO it was abrogated (Figure 7b). When cells were incubated for 15 min with proteasome inhibitors (Lactacystin, MG132, Proteasome Inhibitor I, 10 mM), washed, and then stimulated with SCF, vesicles containing internalized c-kit molecules showed an increase in size and number in most of the cells examined (Figure 7c). The observed vesicles therefore most likely represent early endosomes containing internalized SS-EYFP-kit molecules which are about to be degraded by the proteasome machinery of the cell. As a control we assessed tyrosine phosphorylation of SS-EYFP-kit from SCF stimulated cells treated with PAO to exclude that PAO influenced ligand induced phosphorylation of the receptor (Figure 7d). Upon PAO treatment of SCF induced phosphorylation was even enhanced possibly reflecting accumulation of phosphorylated receptor due to blocked internalization.
Cholesterol extraction from the cell membrane with methyl-β-cyclodextrin (MCD)
Cholesterol is an essential structural component of lipid raft membrane microdomains (Simons and Ikonen, 1997). To test whether c-kit function and internalization depends on the integrity of lipid rafts we analysed SCF-induced translocation of SS-EYFP-kit molecules in cells preincubated at different concentrations of MCD, a compound which has been shown to lead to the disruption of lipid rafts (Keller and Simons, 1998). Vesicle appearance was drastically reduced in cells incubated in 20 mM MCD for 45 min prior to stimulation (compare Figure 8a and b) and was completely abrogated in cells preincubated with 30 mM MCD (Figure 8c). This suggests that c-kit molecules could be present in lipid rafts and that these microdomains may be required for regular SCF-induced internalization of the receptor. Reduced internalization of the receptor is not due to diminished phosphorylation of the receptor since we observed even enhanced tyrosine phosphorylation of the receptor upon treatment of the cells with MCD (Figure 8d).
The use of EGFP to visualize proteins has opened a wide field of applications including in vivo subcellular trafficking/colocalization studies and methods using the biochemical properties of EGFP, e.g. fluorescence resonance energy transfer (FRET) (Gordon et al., 1998), fluorescence recovery after photobleaching (FRAP) (Oliferenko et al., 1999), proximity imaging (PRIM) (De Angelis et al., 1998). With the EGF-receptor (epidermal-growth factor) C-terminal fusion of EGFP resulted in a construct unperturbed by the fusion with EGFP. This construct was successfully used to elucidate the internalization process of an RTK (Carter and Sorkin, 1998). The dimerization process of c-kit upon SCF stimulation has been analysed in a study using FRET in combination with fluorochrome labeled antibodies (Broudy et al., 1998).
In order to study the activation dependent internalization process of c-kit we were interested in the creation of a biologically active EGFP fusion construct which would overcome the need for the labeling procedure and would allow detection of c-kit in a broad range of analytical setting. Insertion of EYFP downstream of the signal sequence of c-kit created a functional fusion construct (SS-EYFP-kit) which showed comparable activity to c-kit WT as assessed by SCF induced tyrosine autophosphorylation and activation of PKB/Akt. Furthermore, expression of a constitutively activated mutant of SS-EYFP-kit in Ba/F3 cells led to the same extent of IL-3 independent growth compared to the non-tagged c-kit mutant. The unusual location of EYFP between signal sequence and extracellular domain was chosen because the simple C-terminal fusion unexpectedly caused constitutive activation of c-kit. The reason for this ligand-independent activation is unclear. Other receptors like the EGFR have been fused to EGFP in a similar way and apparently no constitutive activation has been observed (Carter and Sorkin, 1998). It is possible that the presence of EGFP at the C-terminus influences the folding of the kinase domain and hereby causes intramolecular activation. Interestingly, only the mature, fully processed form of this chimera exhibited constitutive tyrosine phosphorylation indicating that either glycosylation or localization to the membrane induces autophosphorylation of this c-kit-EGFP chimera. Our novel approach to create an extracellular fusion with EGFP might represent a general means to create an EGFP-receptor fusion protein, when the intracellular function is critically altered by EGFP.
We show that SCF induced activation of SS-EYFP-kit results in translocation of the fusion construct to endosomal vesicles. Vesicles were localized closed to the membrane as determined by Z-scan analysis and showed tremendous mobility as analysed by time lapse imaging. The observed tracks on which the vesicles moved were mostly radial and the directions of vesicles were mainly towards the perinuclear region and contain internalized receptor. However, vesicular structures moving towards the periphery were also observed. Since the c-kit receptor does not seem to become recycled, vesicles moving to the periphery of the cell most likely contain newly synthesized protein, which is transported to the surface. This hypothesis is in line with the kinetics of cycloheximide sensitive reconstitution of c-kit at the cell surface of Ba/F3 cells stably expressing c-kit. Interestingly, vesicle tracks seemed to be rather non-variable and vesicles subsequently moving in the same or different directions in the same area of the cell were observed to use the same track. Therefore it might be speculated that these vesicles are transported along filaments.
We observed cells for 200 s with a cycle time of 10 s. Digital imaging of the vesicle tracks enables determination of the velocity of single vesicles and ranged from 0.05 to 0.2 μm/s. Since the distances between two subsequent locations of the same vesicle vary considerably, the vesicle movement seems to be rather non-continuous. This suggests that the machinery moving these vesicles seems to function in a ‘stop-and-go’ manner rather than in continuous and steady motion.
Internalization and appearance of c-kit in early endosomes required tyrosine kinase activity and was well detectable after about 20 min of SCF stimulation. Significantly, addition of SCF to cells expressing the W42 mutant fusion construct lacking inducible kinase activity did not result in visible vesicle formation. This result is in line with the observation that SCF stimulation of the W42 mutant led to internalization at a reduced rate (Yee et al., 1994). We hypothesized that constitutive activation of c-kit by dimerization of the V558G mutation might result in permanent internalization of c-kit molecules and subsequent constitutive vesicle formation. Constitutive vesicle formation was seen in some cells expressing SS-EYFP-kit V558G, but not in all, and no change was apparent after addition of SCF. In line with this observation, Western blot analysis did not show enhanced tyrosine phosphorylation of SS-EYFP-kit V558G after stimulation with SCF.
The mutant Y719F deficient in the activation of the PI3-kinase pathway showed similar vesicle formation upon ligand induced activation of the receptor. This observation is in line with a previous report stating similar internalization of c-kit WT and the Y719F mutant under normal conditions (Gommerman et al., 1997). For the PDGF receptor Joly et al. (1995) have reported that PI3-kinase binding sites are not required for internalization of PDGF receptor but are required to divert the PDGF receptor to a degradative pathway. In contrast, for the Flt3/Flk2 receptor tyrosine kinase Beslu et al. (1996) have shown that PI3-Kinase is not required for mitogenesis or internalization of the receptor. It seems that the internalization process itself does not depend on activation of PI3-Kinase, whereas the further degradation of the mentioned receptors seems to be differentially affected by this pathway. Interestingly, SCF induced translocation of mutants Y567F and 569 (both sites have been reported to be involved in SCF induced Src activation (Lennartson et al., 1999)) to vesicular structures was significantly reduced. Consistent with this finding, pharmacological inhibition of Src has been shown to result in abolishment of c-kit internalization upon stimulation with SCF (Broudy et al., 1999).
Vesicle appearance upon SCF stimulation of cells expressing SS-EYFP-kit WT was inhibited by phenylarsine, a trivalent arsenic which has been reported to interfere with receptor internalization by interaction with vicinal dithiols. In turn, vesicle accumulation was observed when proteasomes were blocked by addition of cell permeable proteasome inhibitors. Both observations taken together strongly suggest that the observed vesicles in fact represent structures of the endosomal pathway.
As a new aspect of receptor mediated signaling the involvement of lipid rafts as platforms for attachment of proteins has been proposed (Kurzchalia and Parton, 1999; Simons and Ikonen, 1997). Cholesterol-sphingolipid clusters are the major component of these rafts and it has been shown that removal of cholesterol results in disturbances of signaling events normally taking place within these rafts (Keller and Simons, 1998; Moran and Miceli, 1998). The fact that preincubation of the cells in MCD drastically reduced vesicle formation suggests that c-kit is present in these rafts and that the integrity of functional rafts may be a prerequisite for internalization of c-kit following SCF stimulation.
Using our construct in combination with in vivo imaging we have been able to draw a detailed picture of the internalization process of c-kit following SCF induced activation.
Materials and methods
Reagents and antibodies
Mouse recombinant SCF was purchased from R&D Systems GmbH, Weisbaden, Germany. Polyclonal anti c-kit antibodies were obtained from Santa Cruz Biotechnology Inc., Heidelberg, Germany (C-19, rabbit, and M14, goat). Polyclonal anti-EGFP antibody was obtained from Clontech, Hamburg, Germany, the monoclonal antibody (12CA5) against the HA-Tag from Boehringer/Roche, Mannheim, Germany. Phospho-specific Akt antibody (Ser 473) from New England Biolabs GmbH (Schwalbach/Taunus, Germany). Anti-phosphotyrosine antibodies were purchased from Upstate Biotechnology, Lake Placid, NY, USA, (4G10) and Pharmingen, Hamburg, Germany (PY20). Primers were obtained from a commercial source (MWG-Biotech GmbH, Ebersberg, Germany). The HA tagged PKB/Akt construct was a generous gift from Dr Thomas Franke, Department of Pharmacology, Columbia University, New York, NY 10032, USA.
Cloning of c-kit-EGFP fusion constructs
All c-kit constructs used in this study were cloned into the mammalian expression vector pCDNA 3.1 (Invitrogen, Groningen, The Netherlands). c-kit-EGFP: The stop codon of the murine c-kit cDNA was deleted and a BamHI site was inserted using PCR based primer extension. Using the same method a 3× glycine linker connected to a BamHI site was added to the EGFP cDNA SS-EYFP-kit: Using PCR based site directed mutagenesis (Stratagene, Heidelberg, Germany) an EcoRI site was inserted directly downstream of the signal sequence of the murine c-kit cDNA using the following primer: 5′ CTG CTC CGT GGC CAG ACA GAA TTC GCC ACG TCT CAG CCA TCT GC 3′. The EYFP cDNA was equipped with a linker of three glycines and flanking EcoRI sites and inserted into the mutated c-kit cDNA using the EcoRI site. The mutant c-kit constructs were obtained by PCR based site directed mutagenesis with primers containing the indicated amino acid changes on the nucleotide level. All mutations were verified by sequencing or restriction analysis, if possible.
Cell culture and transfection methods
293 and COS7 cells were maintained in DMEM (GIBCO–BRL, Karlsruhe, Germany) supplemented with 10% FCS (Biochrom KG, Berlin, Germany). 293 cells were transfected using DOTAP (Boehringer/Roche, Mannheim, Germany), COS7 cells were transfected using Gene Porter (GTS Inc., Biozol GmbH, Eching, Germany) according to the manufacturer's recommendations.
Cells were serum starved in DMEM lacking FCS for at least 6 h and stimulated with 500 ng/ml SCF for the times indicated.
Inhibition of c-kit internalization and proteasome inhibition
To inhibit c-kit internalization cells were incubated for 5 min with 50 μM PAO (phenylarsine oxide)/DMSO for 5 min at 37°C (Sigma, Taufkirchen, Germany). For proteasome inhibition cells were incubated for 5 min at 37°C in media containing lactacystin/MG132/Proteasome Inhibitor I/DMSO (Calbiochem-Novabiochem, Schwalbach, Germany) at a concentration of 10 μM. Control cells were incubated in media containing the same concentration of DMSO. Cells were rinsed twice with prewarmed DMEM lacking FCS before stimulation.
Disruption of lipid rafts
For cholesterol extraction with methyl-β-cyclodextrin (MCD) (Sigma, Taufkirchen, Germany) cells were incubated in DMEM containing MCD at the concentrations indicated for 45 min at 37°C. Control cells were incubated in media lacking MCD. Cells were washed twice with prewarmed media before stimulation with SCF.
Cell proliferation assay
3×104 cells per well were plated into 96-well plates in 200 μl of their respective media. After the indicated time period, the viable cells in each well were assayed for their ability to transform MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (CellTiter 96®, Promega, Mannheim, Germany) into a purple formazan. Forty μl of a 10 mg/ml MTS solution were added in each well. After an incubation period of 4 h at 37°C the reaction was stopped by adding 50 μl 10% SDS and the absorbance of the samples was measured in an ELISA reader at 490 nm.
Ba/F3 cells stably expressing c-kit WT were analysed for surface c-kit expression before and after 45′ treatment with 500 ng/ml SCF with or without addition of 75 μg/ml (267 μM) cycloheximide (Calbiochem, Darmstadt, Germany). Cells were analysed at 0, 45 and 90 min after the start of SCF stimulation. To assess reconstitution of c-kit at the cell surface, SCF containing media was removed, cells were washed three times with PBS and cultivated for the indicated additional time with or without cycloheximide. For detection of c-kit expression by FACS, cells were stained with a PE-labeled c-kit antibody (ACK45, Pharmingen, Heidelberg, Germany) or control antibody (A95-1, Pharmingen, Heidelberg, Germany) and measured on a Coulter XL FACS machine (Coulter, Krefeld, Germany) in the FL1 and FL2 gate.
Immunoprecipitations and immunoblotting
Immunoprecipitations and immunoblotting was done as previously described (Duyster et al., 1995). Briefly, SCF stimulated or non-stimulated cells were harvested in cold PBS containing 1 mM Sodium Vanadate, pelleted and lysed in lysis buffer containing 10 mM Tris-HCl (pH 7.4), 5 mM EDTA, 130 mM NaCl, 1% Triton, 1 mM phenylmethylsulfonyl fluoride, 1 mM Na3VO4 and 10 mg/ml of each phenantroline, aprotinin, leupeptin and pepstatin. After clarification by centrifugation and preclearing with protein A-Sepharose, antibody-protein complexes were brought down with 30 μl of protein A-Sepharose (Amersham/Pharmacia Biotech AB, Freiburg, Germany). For immunoprecipitation of c-kit 2 μg of anti-kit M14 was used. Lysates and bound fractions of immunoprecipitations were subjected to SDS–PAGE and blotting was performed on PVDF membranes (Immobilon-P, Millipore GmbH, Eschborn, Germany). Immunodetection of phosphotyrosine was done using a mixture of the anti-phosphotyrosine antibodies 4G10 and PY20. For detection of immunoprecipitated c-kit or c-kit from lysates anti-kit C19 was used. In order to examine activation of PKB/Akt lysates from cells overexpressing HA-tagged Akt were first analysed with an anti-phospho-Akt antibody. After stripping the same membrane was probed with an anti-HA antibody to verify equal expression levels of HA-Akt. Blots were developed using SuperSignal® chemoluminescent substrates from Pierce Chemical Company (KMF GmbH, St. Augustin, Germany).
Visualization of c-kit-EGFP fusion constructs in fixed cells
Fixation and detection of EGFP fusion constructs in fixed cells was done as previously described (Coutinho et al., 2000). Briefly, COS7 cells were cultured and transfected on gelatin-coated chamber slides (Nunc GmbH, Wiesbaden, Germany). Seventy-two hours after transfection, cells were starved for at least 6 h, stimulated with SCF as indicated, washed with cold PBS containing 1 mM Vanadate and fixed with 3.7% paraformaldehyde for 15 min. Cells were then washed twice with PBS, overlaid with mounting medium (Molecular Probes), covered with a coverslide and visualized using a fluorescence microscope (Olympus optical Co. GmbH, Hamburg, Germany) connected to a digital imaging system (TILL Photonics, Munich, Germany). For detection of different fluorochromes the appropriate filter sets were used (Chroma, AHF AG, Tuebingen, Germany). The fluorescence information of the c-kit-fusion constructs (green channel) was superimposed onto the transmission picture of the cell (red channel) in order to facilitate subcellular localization of the fluorescence signal.
Manual Z-scan analysis was performed by focusing three levels (supranuclear: Red channel; epinuclear: Blue channel; peripheral: Green channel) of the adherent COS7 cell showing vesicle formation after SCF stimulation. All three channels were digitally combined in the RGB picture.
Time lapse imaging of c-kit molecules in living cells
COS7 cells expressing SS-EYFP-kit were grown on a dish with an integrated coverslide. Using an inverted microscope (Olympus IX-50) equipped with a temperature control unit time lapse imaging of cells was performed at 37°C for 200 s with an imaging cycle time of 10 s. The sum of all vesicle movements during 200 s (Δt=200 s) (red channel) was superimposed on the initial picture of the cell (green channel). The software for imaging vesicle tracks was kindly provided by TILL Photonics, Munich, Germany.
Beaumont V, Hepworth MB, Luty JS, Kelly E, Henderson G . 1998 J. Biol. Chem. 273: 33174–33183
Beslu N, LaRose J, Casteran N, Birnbaum D, Lecocq E, Dubreuil P, Rottapel R . 1996 J. Biol. Chem. 271: 20075–20081
Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T . 2000 Nat. Genet. 24: 157–162
Broudy VC . 1997 Blood 90: 1345–1364
Broudy VC, Lin NL, Buhring HJ, Komatsu N, Kavanagh TJ . 1998 Blood 91: 898–906
Broudy VC, Lin NL, Liles WC, Corey SJ, O'Laughlin B, Mou S, Linnekin D . 1999 Blood 94: 1979–1986
Carter RE, Sorkin A . 1998 J. Biol. Chem. 273: 35000–35007
Caruana G, Cambareri AC, Ashman LK . 1999 Oncogene 18: 5573–5581
Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N . 1997 Leukemia 11: 1404–1428
Coutinho S, Jahn T, Lewitzky M, Feller S, Hutzler P, Peschel C, Duyster J . 2000 Blood 96: 618–624
De Angelis DA, Miesenbock G, Zemelman BV, Rothman JE . 1998 Proc. Natl. Acad. Sci. USA 95: 12312–12316
Deberry C, Mou S, Linnekin D . 1997 Biochem. J. 327: 73–80
Duyster J, Baskaran R, Wang JY . 1995 Proc. Natl. Acad. Sci. USA 92: 1555–1559
Feng Y, Minnerly JC, Zurfluh LL, Joy WD, Hood WF, Abegg AL, Grabbe ES, Shieh JJ, Thurman TL, McKearn JP, McWherter CA . 1999 Biochemistry 38: 4553–4563
Fischer M, Goldschmidt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grotzinger J, Rose-John S . 1997 Nat. Biotechnol. 15: 142–145
Gommerman JL, Rottapel R, Berger SA . 1997 J. Biol. Chem. 272: 30519–30525
Gordon GW, Berry G, Liang XH, Levine B, Herman B . 1998 Biophys J. 74: 2702–2713
Hallek M, Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb HJ, Druker B, Griffin JD, Emmerich B, Ullrich A . 1996 Br. J. Haematol. 94: 5–16
Joly M, Kazlauskas A, Corvera S . 1995 J. Biol. Chem. 270: 13225–13230
Kanakura Y, Furitsu T, Tsujimura T, Butterfield JH, Ashman LK, Ikeda H, Kitayama H, Kanayama Y, Matsuzawa Y, Kitamura Y . 1994 Leukemia 8: (Suppl 1) 18–S22
Keller P, Simons K . 1998 J. Cell. Biol. 140: 1357–1367
Krystal GW, DeBerry CS, Linnekin D, Litz J . 1998 Cancer Res. 58: 4660–4666
Kurzchalia TV, Parton RG . 1999 Curr. Opin. Cell. Biol. 11: 424–431
Langley KE, Bennett LG, Wypych J, Yancik SA, Liu XD, Westcott KR, Chang DG, Smith KA, Zsebo KM . 1993 Blood 81: 656–660
Lennartson J, Blume-Jensen P, Hermanson M, Ponten E, Carlberg M, Ronnstrand L . 1999 Oncogene 18: 5546–5553
Li Q, Kondoh G, Inafuku S, Nishimune Y, Hakura A . 1996 Cancer Res. 56: 4343–4346
Liu L, Cutler RL, Mui AL, Krystal G . 1994 J. Biol. Chem. 269: 16774–16779
Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, Lu HS, Schechter NM . 1997 Proc. Natl. Acad. Sci. USA 94: 9017–9021
Mahajan NP, Linder K, Berry G, Gordon GW, Heim R, Herman B . 1998 Nat. Biotechnol. 16: 547–552
Miyazawa K, Toyama K, Gotoh A, Hendrie PC, Mantel C, Broxmeyer HE . 1994 Blood 83: 137–145
Moran M, Miceli MC . 1998 Immunity 9: 787–796
Oliferenko S, Paiha K, Harder T, Gerke V, Schwarzler C, Schwarz H, Beug H, Gunthert U, Huber LA . 1999 J. Cell. Biol. 146: 843–854
Serve H, Yee NS, Stella G, Sepp-Lorenzino L, Tan JC, Besmer P . 1995 EMBO J. 14: 473–483
Shimizu Y, Ashman LK, Du Z, Schwartz LB . 1996 J. Immunol. 156: 3443–3449
Simons K, Ikonen E . 1997 Nature 387: 569–572
Thommes K, Lennartsson J, Carlberg M, Ronnstrand L . 1999 Biochem. J. 341: 211–216
Timokhina I, Kissel H, Stella G, Besmer P . 1998 EMBO J. 17: 6250–6262
Wakioka T, Sasaki A, Mitsui K, Yokouchi M, Inoue A, Komiya S, Yoshimura A . 1999 Leukemia 13: 760–767
Wu H, Klingmuller U, Besmer P, Lodish HF . 1995 Nature 377: 242–246
Yee NS, Hsiau CW, Serve H, Vosseller K, Besmer P . 1994 J. Biol. Chem. 269: 31991–31998
This work was supported by a grant to J Duyster from the José-Carreras Stiftung and Mildren-Scheel Siftung and by SFB grant No 456 to J Duyster and C Peschel. T Jahn and C Miething are supported by a fellowship from the Deutsche José-Carreras Stiftung. We thank Kenneth I Weinberg, Children's Hospital Los Angeles, for very helpful suggestions and comments and critically reading the manuscript. We thank Dr Christian Heinemann, TILL Photonics, for friendly and skilful support. We thank Claudia Mugler for technical assistance.
About this article
Cite this article
Jahn, T., Seipel, P., Coutinho, S. et al. Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain. Oncogene 21, 4508–4520 (2002). https://doi.org/10.1038/sj.onc.1205559
- signal transduction
Journal of Cellular and Molecular Medicine (2020)
Cell Death & Disease (2019)
Sustained Mutant KIT Activation in the Golgi Complex Is Mediated by PKC-θ in Gastrointestinal Stromal Tumors
Clinical Cancer Research (2017)